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Report to the Medical Research Council by its Lung Cancer Working Party
Prepared on behalf of the participating members by
P.M. Fayers (Statistician), N.M. Bleehen (Chairman until October 1989), D.J. Girling
(Secretary) & R.J. Stephens (Data Manager)
Summary Three hundred and sixty-nine patients in an MRC study of combination chemotherapy and
radiotherapy for small-cell lung cancer of limited extent were asked to complete a Daily Diary Card which
enabled an assessment of their quality of life to be made during and after treatment. The information derived
from the card suggests that although cytotoxic chemotherapy has an adverse effect upon quality of life, this
impairment only affects the first 2 or 3 days following each course of treatment, although there is also a small
deterioration which may be associated with the 'nadir' effect of the blood counts about 10 days after each
course. These results should assist physicians in counselling patients about the likely effects of treatment. Just
over half of the patients (196) were subsequently randomised to either a further six courses of maintenance
chemotherapy or no further chemotherapy, and it is also shown that the patients allocated to no maintenance
chemotherapy experienced a gradually deteriorating quality of life, as opposed to the brief but more severe
adverse effects which occurred following each course in the maintenance chemotherapy group; this supports
the hypothesis of a palliative effect in this latter group. The findings demonstrate that the Daily Diary Card is
a sensitive instrument capable of yielding useful information.
Small-cell lung cancer carries a poor prognosis but is usually
highly sensitive to cytoxic chemotherapy and radiotherapy.
Such treatment policies aim to control the symptoms of the
disease, prolong survival, and will cure a small proportion of
the patients. However, although the primary disease and its
metastases may be controlled, and therefore the symptoms
reduced, the adverse effects of treatment may be unpleasant,
and all too often there is little gain in the number of long
term survivors. A Medical Research Council (MRC) study of
chemotherapy in the treatment of small-cell lung cancer
attempted to assess this (MRC Lung Cancer Working Party,
1989). Since long term survival is uncommon, the patients'
quality of life whilst receiving treatment is important. In
particular, since the chemotherapy may be toxic it is
desirable to limit its duration to the shortest that can achieve
maximum benefit. These considerations have led to an in-
creased interest in methods of assessing quality of life, and
they are now frequently included in clinical trials. Such
assessments may be made by the clinician, a nurse, the
patient or a relative; usually, however, they only report a
summary of the patient's quality of life since the previous
attendance at the hospital or over some similarly long time
span. In earlier studies the MRC Lung Cancer Working
Party had used standard scales applied by clinicians at such
intervals to assess performance status and general health. In
this study it was decided to develop a Diary Card to be
completed by patients on a daily basis (Figure 1) so as to
examine the way in which the patient's general health varies
during and after a course of treatment. The results from this
Daily Diary Card are presented, and the problems associated
with developing and applying new instruments for assessing
quality of life are discussed. Similar cards are now being used
in a number of current MRC studies, and by other groups
(Geddes et al., 1990).
Methods
Patients and outline ofstudy
The design of the study is reported in greater detail elsewhere
(MRC Lung Cancer Working Party, 1989). In this paper
only those study patients with limited disease are described,
since the protocol treatment for patients with extensive
disease was different. In essence, patients with small-cell lung
cancer were eligible for the study if they were aged 75 years
or less, and had 'good performance status', that is were able
to get out and about even if activity was restricted. An initial
induction period of treatment of six courses of chemotherapy
was given, with radiotherapy between courses two and three.
Patients who were responding to treatment were then ran-
domly assigned to a policy of maintenance (M) or no
maintenance (NoM) chemotherapy. Since the benefits of
treatment in terms of survival were uncertain, it was con-
sidered important to investigate the quality of life during the
M/NoM period in order to compare the possible gain in
survival duration against the adverse effects of continued
treatment.
Details oftreatment policies
All patients were given induction treatment with six courses
of cytotoxic chemotherapy; this comprised chemotherapy on
3 consecutive days: etoposide 120 mg m-2, cyclophosphamide
1 g m-2, methotrexate 35 mg m-2, and vincristine 1.3 mg m-2
intravenously on day 1, then etoposide 240 mg m-2 orally or
120 mg m-2 intravenously on days 2 and 3. Courses were
given at 3-week intervals. In addition, megavoltage
radiotherapy was given over 3 weeks between the 2nd and
3rd courses of chemotherapy, starting 3 weeks after the
second course. A radiotherapy midline dose of 40 Gy in 15
daily fractions 5 days per week over 3 weeks was delivered
through planned portals to the primary site and mediastinal
lymph nodes. At the end of the initial induction period of
chemotherapy patients showing complete or partial response
to treatment (World Health Organization, 1979) were allo-
cated at random to receive either no further treatment (No
Maintenance - 'NoM') or a further six courses of the same
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INSTRUCTIONS
Please completethis card every evening after
your last meal, to tell us how you have been
feelingduringthe past24hours; this will help
us to make a thorough assessment of your
illness and any treatment that you may need.
Thecodesto beused are shown on the reverse
side ofthe week 5 se,tion.
Mon Tue Wed Thu Fri Sat Sun
Please give details ofany other problems or
changes in your general health
Ct d JrY,4-Je
Figure 1 Daily Diary Card.
chemotherapy (Maintenance - 'M') but at intervals of 4
weeks instead of 3.
Physicians' assessment ofquality oflife
Patients attended every 3 weeks during the induction period
and every 4 weeks during the M/NoM period. At each
attendance the clinician assessed the patient's overall condi-
tion and level of activity (Table I). In addition, the patient
was asked about adverse reactions since the last attendance.
Daily Diary Card
At their first attendance upon entering the trial the patients
were given the Daily Diary Card (Figure 1; Fayers & Jones,
1983), and were shown how to complete it every evening
after their last meal, recording how they felt over the
previous 24 h. Each card covered a period of up to 5 weeks,
since although the clinic attendances were intended to be
every 3 or 4 weeks, there were often delays. There were five
questions, all graded on a five-point scale from one (most
favourable) to five (least favourable); see Table I. Because the
card was to be completed on a daily basis it was decided that
only a few questions should be asked, and that they should
have simple wording. As a consequence, although the patients
were asked about 'mood' and 'anxiety' there was no attempt
to use formally defined psychometric scales as would nor-
mally be implied by such terms. Although the questions
about overall condition and physical activity are on a five-
point scale for both the physicians' assessment and the diary
card, there are minor differences in the wording used, parti-
cularly in the assessment of physical activity; this occurred
because the physicians' assessment was in the same form as
in previous MRC studies, whereas the diary card used
simplified questions.
Results
Patients in the study
Between June 1981 and February 1985, 369 patients with
limited disease were admitted to the study from 27 centres in
the United Kingdom.
Survival
The median survival period from the start of treatment was
41 weeks (MRC Lung Cancer Working Party, 1989); of the
Table I Scales used on the Daily Diary Card and by the physician
Patients'assessment (Diary Card) Physicians'assessment
Overall Condition:
1. Verywell 1. Excellent
2. Well 2. Good
3. Fair 3. Fair
4. Poor 4. Poor
5. Very ill 5. Verypoor
Physical Activity:
1. Normalwork/housework 1. Atwork oractive retirement
2. Normalwork butwitheffort 2. Full activity butnotatwork
3. Reduced activity butnot 3. Outand about, butactivity
confined to home restricted
4. Confined tohome/hospital 4. Confined tohomeorhospital
5. Confined to bed 5. Confined to bed
Vomiting:
1. None
2. Poorappetite
3. Feltsick butwasn't
4. Sickonce
5. Sickmore thanonce
Mood:
1. Veryhappy
2. Happy
3. Average
4. Miserable
5. Verymiserable
Anxiety:
1. Verycalm
2. Calm
3. Average
4. Anxious
5. Veryanxious
369 patients in the study, 196 (53%) who were alive and
responding after the initial six courses of treatment were
allocated at random to M (97 patients) or NoM (99). There
was no statistically significant difference in survival between
the M and NoM series (P = 0.27, log-rank test) although the
median survival periods from randomisation were 37 weeks
(M) and 29 weeks (NoM). One hundred and twenty-six
patients were alive 6 months after randomisation, 54 at 1
year, 14 at 2 years and 11 at 3 years.
Patients' compliance in use ofdiary card
It was realised that a study collecting daily information
about quality of life may have poorer compliance levels thanQUALITY OF LIFE IN SCLC 301
if a questionnaire were used at the time of attending a clinic.
Table II shows the level of compliance obtained with the
Daily Diary Card. As few cards were received from patients
in the last few weeks of life, the final month of survival was
ignored whilst analysing the compliance. During the induc-
tion period 23% of the patients returned no information at
all, and a further 28% returned cards covering less than half
the induction period, or less than half their survival period, if
they failed to survive that long. However there were marked
differences between centres, with the patients from 37% of
the 27 centres consistently returning most of their cards while
at the other extreme thol
information at all. Fortuna
view, the level of complianm
series, and thus between-trn
remain unbiased. However
question as to whether the
patients really feel about t
ried out additional analyse
survival were compared fc
pliers' and 'bad compliers'
quality of life assessments
of entry to the study were
results are shown in Tabl4
Table II Compliance durini
during the first 3 Im
% ofdata
receivedb
Nil
1 -50%
51-100%
Total patients
Overall % ofdata
returned in thisperiod
a'Induction' is from the tim
or, if no allocation was made
domisation). If a patient died b
date of death minus 1 month
months after allocation, or unt
was earlier. bFor example, a p
ing cards covering 1 month v
data received'.
Table III Percentage of Dia
patients' age, survi
i
Number ofpatients
Median age (years)
Median survival (days)
(no significant suI
Percentage ofpatients with
Physicians' assessment of
pretreatment level of
physical activity: Not
restricted (grade1 or 2)
Physicians' assessment of
pretreatment overall
condition: Excellent/good
(gradeI or2)
Patients' assessment of
overall condition until
time ofsecond course:
Good or excellent (75%
oftime at grade1 or 2)
Physicians' assessment of
overall condition at
time ofsecond course:
Good orexcellent
(grade1 or 2)
differences were found in age,but the patients returning most
data appeared to be the healthier ones (Chi-squared for
trend, P <0.02 for physicians' assessments of activity and
patients' self-assessment of overall conditions, P <0.001 for
physicians' assessments of overall condition).
Quality of life
Quality oflife charts
se from one centre returned no Figure 2 shows the percentage of patients reporting them-
ately, from the statistical point of selves in the worst two grades, namely 4 to 5 (see Table I),
ce was similar in the M and NoM for each day in the first year from the start of induction
eatment comparisons are likely to chemotherapy. The charts for activity were similar to those
the poor compliance raises the for other questions and to conserve space are not displayed.
results are representative of what The figure is confined to those patients alive at 6 months.
'heir treatment. We therefore car- The number of patients surviving decreased substantially as
s: the baseline characteristics and the study progressed; during the first course 116 patients (52
r patients who were 'good com- M and 64 NoM) completed cards, but by 40 weeks the
(Table III, upper part). Similarly, number of patients returning information was 61 (37 M and
made by the physician at the time 24 NoM).
compared for the two groups; the Although the chemotherapy (Ct) was scheduled to be given
e III (lower part). No significant at intervals of 3 weeks (induction) or 4 weeks (maintenance),
in practice it was sometimes delayed for reasons such as
toxicity or holidays; however, the total amount of delay was
similar in the M and NoM groups. Since each course of
gthe induction chemotherapy and chemotherapy is likely greatly to affect the general health of
nonths of follow-up perioda the patients, the mean time between each course was cal-
culated and the results for each patient were realigned to this
Follow-upperiod schedule. The figure clearly shows the effect of chemotherapy
Induction M NoM in producing a few days of diminished quality of life. The
No. % No. % No. % pattern of cycles is broken by the radiotherapy (Rt), which
80 23 34 36 43 44 was given after the first two courses. The M group continued
95 28 13 14 18 18 to display the same pattern throughout the 12 courses of
167 49 47 50 37 38 chemotherapy, but there were clear signs of deterioration in
342 100 94 100 98 100 the NoM group about 15 weeks after their last course, with
47 48 40 higher proportions of patients reporting themselves in grades
4 to 5. The NoM patients showed a slight increase in vomiting
e of start until the date of allocation during the later weeks: this may be explained by some receiv-
155 days (the mean time until ran- ing extra palliative treatment, mainly cyclophosphamide.
)efore allocation would have been due, One particularly interesting observation is that most of the
was used. 'Follow-up period' is the 3 charts in Figure 2 also show a small deterioration in quality
til date of death minus 1 month if this of life half way between successive courses. We believe that
atient surviving 4 months and return- this may be associated with the nadir in blood count usually
would be classified under '1-50% of observed at this time. It may also be noted that there is a
prolonged deterioration after the course of chemotherapy
that follows the radiotherapy, reflecting the combined
ry Card data returned, according to haematological toxicity of chemotherapy and radiotherapy;
ival and clinical condition we are unable to explain why this effect is more marked in
PercentageofDiary Carddatareturned one group than the other, despite their receiving identical
0% 1-50% 51-75% 76-100% treatment. Taking the charts pair by pair, there are suggestions that 74 83 60 78 (a) Overall condition: the no maintenance group has a slightly
343 348 338 358 smaller percentage of patients in grades 4 or 5 during treat- rv43al 348ferences: 338-rank 358t) ment, despite their receiving identical treatments; however rviva * difernce:og-athey deteriorated more after week 40 (although the
maintenance group continued to show treatment-related
55 59 68 71 peaks).
(b) Vomiting: the maintenance group continued to show
peaks associated with continuing treatment.
(c) Mood: The no maintenance group was worse after week
63 61 73 85 28, except for small peaks during maintenance treatment.
(d) Anxiety: The pattern was the same as for mood.
79 89 93 Validity
Table IV compares the overall condition on the Daily Diary
Card with the results of the physicians' assessment at the
time of a course of chemotherapy. Since the patients had
55 59 77 81 recorded daily information the scores were averaged. The
table shows simple arithmetic means calculated by coding the
categories 1 to 5; the scores were calculated within four
groups. For this comparison the unit of observation was the
course, not the patient, and so each patient may have been302 P.M. FAYERS et al.
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Figure 2 Percentage of patients reporting themselves in categories 4 or 5, plotted against the number of weeks since start of
treatment.
counted several times. Forty-five per cent of assessments
were, using this scaling, identical and 39% were worse when
made by the patient rather than the physician. However it
should be noted that there is little reason to equate the
patients' scoring with the physicians' assessments using five
groups with the arbitrary boundaries that we chose to use,
and very different results could easily be obtained by choos-
ing a different scale for the comparison. We also examined
the data by weighting the scores recorded close to the time of
the clinic attendance more heavily than earlier scores, so that
the mean is a better reflection of the patients' condition at
the time of the physician's assessment. This made little
difference to the results presented here.
Table V compares nausea and vomiting since the last
course of treatment, as reported by the patient and by the
physician; the patients reported more vomiting on the Diary
Card (vomiting during 626 courses) than was reported by the
physician (360 courses). Additional comparisons, not present-
ed, showed close agreement with respect to patients' and
physicians' assessment of activity. Also, poor overall condi-
tion was associated with weight loss since the previous visit;
Table VI shows, for example, that of the patients graded 4,
51 (58%) lost weight, 27 (31%) did not change, 10 (11%)
gained weight. The corresponding results for patients graded
1 were 25 (23%), 43 (39%) and 41 (38%).
Differences between courses
Table VII shows the duration of vomiting following each
course. As patients continued to receive successive courses
there was no significant change in the number of days in
which they vomited. Over the six courses, for example,
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Table IV Comparison of overall condition, as assesssed by
physician and by patient: number of patients at each grade
Physicians' Patients' assessmenta
assessment 1 2 3 4 Total
1. Excellent 61 97 43 3 204
2. Good 69 315 353 20 757
3. Fair 20 90 247 47 404
4+ 5. Poor 0 6 50 26 82
Total 150 508 693 96 1447
aPatients' assessment = average over previous 3 weeks, grouped as:
I = less than 1.5; 2 = 1.5 to 2.49; 3 = 2.5 to 3.49; 4 = 3.5 or more.
Table V Comparison of patients' and physicians' assessments of
nausea and vomiting following the first six courses of chemotherapy:
number of courses reported
Physicians' Patients' assessment
assessment No data None Nausea Vomiting Total
Not reported 554 125 78 371 1128
Nausea 80 27 31 79 217
Vomiting 115 49 20 176 360
Total 749 201 129 626 1705
Table VI Patients' assessment of overall condition compared with
weight loss over the sample period
Patients' assessmentp
Weight change 1 2 3 4 Total
Weightloss 25 95 210 51 381
Nochange (less than 43 179 228 27 477
1 kg)
Weightgain 41 132 140 10 323
Total 109 406 578 88 1181
aSame scale asTable IV.
Table VII Percentage of patients according to days of vomiting
following each coursea
Course
Days 1 2 3 4 5 6
0 27 22 16 28 25 19
1 37 36 42 28 27 21
2 20 25 24 24 31 44
3 5 10 4 9 12 11
4 3 2 3 2 1 2
5+ 8 4 11 8 4 3
Number of patients 60 130 100 96 84 63
aAt each course data were only included if the patient had pro-
vided data for all of the following 7 days.
similar percentages of patients reported 2 or more days of
vomiting. Similarly, no differences between courses were seen
in the answers to the other questions on the diary card.
Anxietypreceding a course oftreatment
Although there was little suggestion from the charts, it was
thought possible that patients might become anxious or
miserable in the few days prior to a course of treatment. We
therefore analysed in more detail the numbers of patients
reporting themselves to be anxious during the 7 days prior to
the 5th course during the induction period. The fifth course
was chosen because by this time the patients are familiar with
the effects of the treatment; the sixth course might not be
representative, as some of the NoM patients would have
already been told that this is their last course. No patterns
were evident in the numbers, although it is perhaps likely
that a few patients may become more anxious immediately
prior to visiting the hospital whilst others may feel relieved to
be going back for treatment. Additional analyses of the data
preceding other courses showed similar lack of patterns.
Comparison ofM and NoM groups
In addition to the graphical representations, it is possible to
summarise the data in various numerical ways. Table VIII
examines the percentage of days that patients rated
themselves in each category during the 6-week period after
the end of induction treatment. More M than NoM patient-
days were reported in the worse categories (3 to 5) for all
questions, which agrees with the quality of life charts in
which, after the induction period, the area under the curves is
much larger for M patients than for NoM patients.
Table IX, using a different style of presentation, gives the
number of days that patients graded themselves as having
poor overall condition (categories 4, 5). By the second period
larger numbers of the M patients felt ill than NoM patients,
although initially eight of the 22 NoM patients assessed were
in categories 4/5 for at least 5 days.
Discussion
Analysis ofDiary Cards
The diary card has produced large amounts of information
with the 369 patients returning on average more than 100
days of repeated data, representing a total of nearly 200,000
items of information. A natural method of analysis to con-
sider is to reduce the data for each patient to a few summary
scores, such as 'average overall condition'. We have used this
approach in some of the tables. However, there are obvious
difficulties in using any form of averaging process, especially
when attempting to combine severity with duration. For
example, is 1 day of feeling very ill followed by a day of
feeling very well equivalent to 2 'average' days? Furthermore,
if one wishes to use average scores surely it is preferable, not
to say far simpler to implement, to ask the patient to carry
out the averaging and weighting by posing such questions as
'How have you been feeling since your last course of treat-
ment?'.
Table VIII Percentage of patient days in each category in the 6
weeks following course 6a
Overall Physical
condition activity Vomiting Mood Anxiety
Category M NoM M NoM M NoM M NoM M NoM
1 12 14 21 31 75 84 7 8 7 12
2 28 39 16 24 9 7 28 33 33 34
3 49 38 42 36 7 5 52 48 48 41
4 10 8 18 8 2 1 11 10 9 11
5 1 1 3 1 6 3 2 1 3 1
'Based on 47 M and 37 NoM patients with at least 50% of data
available.
Table IX Days at overall condition of poor or very ill (categories 4,
5), following course 6a
0-4 weeks 5-8 weeks
Days M NoM M NoM
0 15 8 16 20
1 4 3 0 1
2 5 2 1 0
3 0 1 3 0
4 1 0 0
5+ 1 8 5 1
Patients 26 22 25 23
aOnly includes patients with all relevant data.304 P.M. FAYERS et al.
The primary objective of using a diary card was to collect
detailed information, so as to explore the patterns of chang-
ing quality of life during the cycles of treatment. This does,
however, result in large quantities of data which are difficult
to summarise and interpret. The ratings for each question are
on discrete five-point ordinal scales which do not necessarily
have linear intervals; there is much missing data with patients
failing to complete data for individual days, not returning
one or more cards, or completely ceasing to fill in cards;
since many patients died within the first few months, there is
'censoring' of the data which may possibly be related to
deteriorating quality of life; patients may have courses of
treatment delayed, omitted, or the dosage reduced, either
because of toxicity and impaired quality of life or simply
because the patient goes on holiday. Difficulties of analyses
and interpretation bedevil the use of any diary cards, and
workers in other fields have experienced similar problems
with daily data (Machin et al., 1987). We have therefore
attempted to analyse and present the results in a variety of
tables and formats, but the simplest and most useful display
is perhaps that of the Figure 2. Whilst not being amenable to
formal statistical significance testing, these charts quite vividly show the changing quality of life between and across
courses of treatment, and appear adequately to reflect the
differences between the policies of treatment. Although we
have displayed separate charts for each question on the card,
the patterns are all closely similar and use of a Likert or
summated scale might be considered as an alternative to this
battery of charts. However, it is doubtful whether a simple
summated scale would be able to represent the overall quality
of life, and other studies have suggested that it may be
preferable to report separate scores (Selby et al., 1984;
Stewart et al., 1981).
Compliance
Compliance is often a problem with self administered assess-
ments (Baum et al., 1979), and depends crucially upon the
manner in which the patient is introduced to the question- naire (van Dam et al., 1983). Such problems are likely to be
greater both for a multicentre study as opposed to a single
centre study, and for a daily diary card than for a question- naire completed when the patient attends for treatment.
However, reports from many centres suggested that if time
was taken to explain that the card has two benefits, namely in assisting with the review of the patients' condition and in
helping to investigate the problems of the treatment, most
patients were willing to complete cards regularly. This was
confirmed by the way that those physicians who most suc-
cessfully used the card, and who presumably also most
encouraged their patients to make full use of it, found that
patients made much use of the blank space at the bottom of
the card to describe how they felt during their treatment. We
observed major differences in the level ofpatient compliance between centres, again suggesting that much of the problem relates to the way in which the cards were administered and
confirming the need to ensure that efforts were made to
provide sufficient motivation for the patients. Those centres
with additional support staff assigned to clinical trials were
likely to obtain higher rates ofcompliance than other centres.
However, the overall levels of compliance were the same in
both the M and NoM group, and we therefore believe that
bias is unlikely to render tests for differences between the two
groups of patients invalid. Patients returning few or none of
the cards may differ from patients returning larger numbers; although age and survival did not appear to relate to com-
pliance there did appear to be an association of compliance with the patient's overall condition. In particular, there was a
suggestion that healthier patients were more likely to com-
plete cards. However, this effect was present in both groups and is therefore unlikely to bias the results. Thus, notwith-
standing the variable level of compliance, we consider the
quality of life data collected during this trial to be represent- ative of the patients entered into the study.
Validity
It is generally recognised that validity is of crucial import-
ance in assessing any new scale (e.g. Feinstein et al., 1986;
Goldberg & Hillier, 1979; Kaplan et al., 1976; Nunnally,
1978). Unfortunately, however, there is a growing awareness
that for quality of life measurements there is no 'gold stand-
ard' against which to compare scales (Boyd et al., 1988;
Derogatis & Spencer, 1984; Kaplan et al., 1976; Selby et al.,
1984; Till et al., 1984) and that indirect methods must be
used. In theory an in-depth psychological interview might
seem to be the ideal yardstick, but in the context of a
multicentre trial this is usually impractical. More import-
antly, however, the act ofconducting an in-depth interview is
very likely to modify a patient's perception of their quality of
life (Brinkley, 1985); many patients are relieved to be able to
discuss how they feel (van Dam et al., 1983; Fallowfield et
al., 1987; Clark & Fallowfield, 1986), and appreciate the
interest that is shown in their quality of life.
Instead one can consider comparing the new scale against
existing instruments. In this case, however, the current
authors would argue that if two scales ask broadly similar
questions about, say, overall condition then it would be most
surprising if the results obtained from both were not also
broadly similar; on the other hand it would be surprising if
the results were identical. Furthermore, if the results were
identical it would merely demonstrate that the new scale
confers no advantages. Thus in general it is of limited interest
to compare two different scales, unless the newer one has
advantages such as being simpler to administer or providing
more useful information. Also, the degree of agreement
between self-assessment of health and physician ratings has
been found to vary from very litle to very high according to
the topic being assessed and it has been suggested that it may
be most practical to choose a scale which is not necessarily
'true' in some absolute sense, but rather which is most useful
in providing comparative data (Hunt et al., 1980).
Undaunted, however, we compared the results obtained
from the clinicians assessment with those from the Daily
Diary Card. In order to make the comparisons it was neces-
sary to average the patients' daily scores, which implicitly
makes the dubious assumptions that the scales are linear (so
that 1 day at grade 2 followed by 1 day at grade 4 is
equivalent to 2 days at grade 3), and also that the physicians'
assessments represent averages of how the patients have felt
since the previous assessment. Although the questions differed
slightly in wording and thus were not directly comparable,
we nevertheless found reasonable agreement. One particular
aspect was of special interest: the patients reported much
higher levels of vomiting after their courses of chemotherapy
than had been recorded by the physicians. However, the form
completed by the physicians did not contain an explicit ques-
tion about vomiting, but merely a general heading of
'adverse reactions'. Since it is likely that the chemotherapy
would induce vomiting in most patients, there seems to be
evidence that the physicians were under-reporting the
incidence of vomiting whilst the self-assessment with the
diary card is likely to be a more accurate representation of
what was happening. There was close agreement between the
patient's and physician's assessment of activity. Also, there
was strong association between the patients' assessments of
overall condition and weight loss since the previous visit.
The patients also answered questions about 'mood' and
'anxiety'; these were loosely worded questions and it is in no
way claimed that they provide a formal assessment of the
analogous psychometric terms; however, we expect the ques-
tions to provide information about the patients' perception
of their general condition. These scores showed similar
associations and patterns as the other measures, and
appeared to contribute little additional information. The
clear patterns in the charts and their interpretation as de-
scribed in the results strongly suggest that the diary card is
yielding valid data, some ofwhich are not available from less
frequent assessments. This claim is also supported by the
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in a version very similar to ours, against EORTC and Spitzer
quality of life assessments; they concluded that the card
succeeded in measuring the more specific variables of the
EORTC questionnaire, but did not address all the areas of
the Spitzer index.
Sensitivity and reliability
The charts show that the diary card was sensitive enough to
detect adverse effects of treatment, particularly the large
day-to-day changes in general health which occur following a
course of chemotherapy. The period of radiotherapy is also
apparent, as is the deterioration in health in NoM patients
after the end of treatment. The time when blood counts are
usually at their nadir is also visible; this also corresponds to
the uneven distribution of deaths during chemotherapy,
noted elsewhere (MRC Lung Cancer Working Party, 1989;
Souhami et al., 1987), which occurs most often about 10 days
after a course. Similarly, the consistency of the effects on
successive courses and in both the M and NoM groups
supports the proposition that the card yields repeatable, sen-
sitive and reliable data. Geddes et al. (1990) found that the
diary card gave reproducible data which reflected the day to
day variation in symptoms during chemotherapy in a way
which the other questionnaires could not.
In summary, it would appear that the diary card is
sufficiently sensitive to detect time and treatment related
changes, and is also sufficiently reliable to be able to yield
repeatable measurements. The results in the charts, with their
natural interpretation, also confirm that the Daily Diary
Card appears to be a valid measure of general health.
Consequences ofpoor compliance
As commented above, compliance has frequently been found
to be a problem in quality of life assessments. What has less
often been noted is that lack of compliance in quality of life
reporting may lead to serious biases the magnitudes of which
are difficult to assess. For example, it may be that patients
with poor quality of life will more often refuse to answer or,
alternatively, it may be those with favourable quality of life
who see little point in reporting how they feel. The former
appeared to be the case in our study, and better compliance
was obtained in healthier patients. Although the between-
group comparisons in the present study are likely to remain
valid, especially since the compliance levels were similar in
the two groups, it is difficult to know how to interpret the
results in terms of the overall health of patients. It should
also be borne in mind that patients in a clinical trial may not
be representative of patients treated under routine conditions.
In particular, the patients may have been more closely
monitored and supervised, and the very act of completing
and returning Diary Cards may have affected the patients'
perception of the care and support that was being given.
Even with a high level of compliance, it would remain unc-
lear as to how applicable the results obained from a scientific
investigation are as an indicator of the quality of life to be
expected in future patients undergoing the same policy of
treatment. Whilst this is also true for most outcomes from
clinical trials in general, it is possible that subjective assess-
ments such as Quality of Life are more strongly influenced.
Quality oflife in clinical trials
Patients in clinical trials are often followed-up more closely
than those treated in routine practice, and the quality of their
treatment may also be better: this frequently leads to
differences even in objective measurements such as length of
survival, with more favourable results being seen in patients
participating in a trial. It is even more likely that quality of
life experienced by patients in a clinical trial will differ from
that of patients outside a trial, and even the act of com-
pleting a daily card may influence their perception of their
condition. It is difficult to know to what extent the absolute
values of the measurements from clinical trials will apply in
general clinical practice, although any differences detected
between study treatment groups are likely to remain valid. It
is also important to consider how quality of life assessments
obtained in a trial may best be used subsequently to affect
the decision process faced by clinicians when deciding how to
allocate or modify the treatment of their patients, since the
experiences of those patients may prove to be very different
from those of the trial patients. Some attempts have been
made to weigh quality of life against duration of survival
(McNeil et al., 1981), also in the form ofQuality-adjusted life
years (QALYs) (Williams, 1985; Kind et al., 1982), but such
approaches remain controversial (Smith, 1987).
Conclusions
In this study there was no clear evidence that extending
chemotherapy beyond six courses prolonged survival,
although there was a suggestion that it may be beneficial in
patients showing a complete response to initial
chemotherapy. However, the results from the Diary Card
show that most of the adverse side effects appear to be
confined to the first few days following a course of
chemotherapy, although there is also a small deterioration
which may be associated with the 'nadir' effect. This applied
to all the dimensions assessed, namely overall condition,
physical activity, vomiting, mood and anxiety. These results
should assist physicians in discussing the likely effects of
treatment with patients, and in counselling them. However,
over 50% of the patients retumed less than half of their
cards and there appeared to be a slight tendency for better
compliance in the healthier patients, possibly suggesting that
side effects may have been underestimated. We have also
shown that some patients allocated to No Maintenance
experienced a gradually deteriorating quality of life, as
opposed to the brief but more severe side effects which
continued to occur following each course in the Maintenance
group. This supports the hypothesis that there was a pal-
liative effect in the M group. We believe the Daily Diary
Card has enabled the effects of the treatment to be examined
in more detail than by using more conventional methods, and
the Medical Research Council Lung Cancer Working Party is
continuing to use similar cards in subsequent studies.
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